Catch up on company announcements, industry insights, partnerships, and milestones. Here’s where we share our progress, and where we’re headed next.
Press Release
Beacon Biosignals Upsizes Series B Financing to Over $97 Million
Beacon Biosignals
News
Beacon Biosignals Named in Fast Company's Most Innovative Companies of 2026!
Beacon Biosignals
Press Release
Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG
Beacon Biosignals
Press Release
Beacon Biosignals Announces Multi-Year Expansion of Strategic Collaboration with Takeda to Advance Narcolepsy Diagnosis and Neurobiomarker Discovery
Beacon Biosignals
Press Release
Beacon Biosignals Raises $86M to Accelerate AI-Driven Insights into Brain Health
Beacon Biosignals
Press Release
Beacon Biosignals Completes Strategic Transaction to Acquire CleveMed
Beacon Biosignals
Press Release
Beacon Biosignals Reports Novel Sleep EEG Results from Multiple Industry Collaborations at the American Epilepsy Society Annual Meeting
Beacon Biosignals
Press Release
FDA Authorizes Beacon’s Dreem 3S as First Sleep Wearable with Predetermined Change Control Plan, Paving the Way for Continuous Algorithm Enhancements in Sleep Monitoring
Beacon Biosignals
Press Release
Beacon Launches HEADFIRST Clinical Trial to Study Sleep EEG in Pediatric Developmental Disorders, Partners with LGS Foundation
Beacon Biosignals